Symmetry: Consistent graft thickness to help support a uniform repair.
Sterility: AlloMax™ meets or exceeds a sterility assurance level (SAL) of 10-6 which is what the FDA recommends for medical devices intending to come in contact with breached skin or compromised tissue.
Science: Preclinical data demonstrating proven blood vessel formation in as little as 7 days.1*
* Preclinical results may not correlate to performance in humans.
The AlloMax™ Surgical Graft is processed by RTI Biologics.
1Greenspan, David C., Ph.D et al. Histology of Surgically Implanted AlloMax™ Surgical Graft.